Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| non-classical monocyte | 16 studies | 22% ± 9% | |
| macrophage | 9 studies | 21% ± 5% | |
| conventional dendritic cell | 6 studies | 23% ± 5% | |
| endothelial cell | 6 studies | 21% ± 5% | |
| monocyte | 5 studies | 19% ± 3% | |
| classical monocyte | 5 studies | 22% ± 4% | |
| myeloid cell | 5 studies | 22% ± 5% | |
| fibroblast | 5 studies | 19% ± 5% | |
| dendritic cell | 5 studies | 32% ± 13% | |
| epithelial cell | 4 studies | 27% ± 10% | |
| ciliated cell | 4 studies | 19% ± 3% | |
| mononuclear phagocyte | 3 studies | 19% ± 3% | |
| endothelial cell of lymphatic vessel | 3 studies | 22% ± 3% | |
| GABAergic neuron | 3 studies | 23% ± 6% | |
| glutamatergic neuron | 3 studies | 24% ± 9% | |
| type I pneumocyte | 3 studies | 19% ± 2% | |
| astrocyte | 3 studies | 22% ± 3% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 4 studies | 17% ± 0% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| lung | 100% | 3459.09 | 578 / 578 | 100% | 22.01 | 1155 / 1155 |
| skin | 100% | 2165.39 | 1808 / 1809 | 100% | 24.90 | 472 / 472 |
| thymus | 100% | 2416.60 | 653 / 653 | 100% | 21.82 | 604 / 605 |
| intestine | 100% | 2497.45 | 966 / 966 | 100% | 21.66 | 525 / 527 |
| uterus | 100% | 3023.64 | 170 / 170 | 100% | 26.46 | 457 / 459 |
| prostate | 100% | 2242.96 | 244 / 245 | 100% | 17.71 | 501 / 502 |
| ovary | 100% | 2138.51 | 180 / 180 | 99% | 13.54 | 427 / 430 |
| stomach | 100% | 1778.40 | 359 / 359 | 99% | 20.01 | 284 / 286 |
| kidney | 100% | 1654.60 | 89 / 89 | 99% | 17.03 | 893 / 901 |
| esophagus | 98% | 2318.38 | 1420 / 1445 | 99% | 18.62 | 182 / 183 |
| breast | 100% | 2697.52 | 459 / 459 | 97% | 17.21 | 1086 / 1118 |
| adrenal gland | 100% | 2215.12 | 258 / 258 | 96% | 12.08 | 220 / 230 |
| bladder | 100% | 2641.14 | 21 / 21 | 96% | 20.07 | 482 / 504 |
| pancreas | 96% | 957.13 | 315 / 328 | 97% | 24.01 | 173 / 178 |
| liver | 95% | 896.68 | 214 / 226 | 97% | 11.46 | 392 / 406 |
| brain | 93% | 786.98 | 2466 / 2642 | 94% | 16.85 | 666 / 705 |
| adipose | 100% | 3095.78 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 3537.48 | 1335 / 1335 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 22.33 | 29 / 29 |
| muscle | 100% | 1808.14 | 803 / 803 | 0% | 0 | 0 / 0 |
| spleen | 100% | 2798.39 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 19.57 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 7.88 | 1 / 1 |
| heart | 100% | 2803.42 | 857 / 861 | 0% | 0 | 0 / 0 |
| peripheral blood | 98% | 2057.72 | 910 / 929 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 95% | 12.88 | 76 / 80 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0006637 | Biological process | acyl-CoA metabolic process |
| GO_0005759 | Cellular component | mitochondrial matrix |
| GO_0005739 | Cellular component | mitochondrion |
| GO_0052816 | Molecular function | long-chain fatty acyl-CoA hydrolase activity |
| GO_0047617 | Molecular function | fatty acyl-CoA hydrolase activity |
| GO_0003986 | Molecular function | acetyl-CoA hydrolase activity |
| GO_0052689 | Molecular function | carboxylic ester hydrolase activity |
| Gene name | ACOT9 |
| Protein name | Acyl-coenzyme A thioesterase 9, mitochondrial (Acyl-CoA thioesterase 9) (EC 3.1.2.-) (Acyl-CoA thioester hydrolase 9) ACOT9 protein Acyl-CoA thioesterase 9 |
| Synonyms | CGI-16 |
| Description | FUNCTION: Acyl-CoA thioesterases are a group of enzymes that catalyze the hydrolysis of acyl-CoAs to the free fatty acid and coenzyme A (CoASH), providing the potential to regulate intracellular levels of acyl-CoAs, free fatty acids and CoASH. Active on long chain acyl-CoAs. |
| Accessions | C9J7L8 Q9Y305 ENST00000492081.1 ENST00000379303.10 [Q9Y305-4] ENST00000494361.5 ENST00000473710.5 F8WDI2 Q96EA2 H7C5Q2 ENST00000379295.5 [Q9Y305-3] ENST00000336430.11 [Q9Y305-1] |